Why is GAAP EPS of $2.58 much higher than adjusted operating EPS of $1.68?

The gap is primarily an unrealized gain of about $405M after tax (about $1.28 per share) from fair value adjustments on derivatives and nuclear decommissioning trust assets. Constellation excludes these mark-to-market and fair value movements from adjusted operating earnings because they are volatile and not indicative of ongoing operations, so the $1.68 figure is the company's preferred measure of underlying performance.

What drove the increase in full-year 2024 guidance?

Management cited commercial business performance ahead of plan in a volatile market, including strong wholesale and retail results, load auction wins, and margin expansion, along with successful portfolio optimization. Higher nuclear output, lower refueling outage costs, and the South Texas Project ownership contribution also supported results. These gains were partly offset by higher O&M from stock price-linked compensation and commercial overperformance pay.

How significant is the PJM capacity auction result for future earnings?

Management estimates the 2025/2026 PJM auction result, which cleared at $270/MW-day versus roughly $100/MW-day previously assumed, could add about $0.25 per share in 2025 and $1.25 per share in 2026 to adjusted operating earnings. These are estimates based on forward market prices as of July 31, 2024, and actual results may vary. The Illinois CMC contract is a comprehensive payment, so capacity price changes do not affect those units' economics, and the capacity impact on PTC-eligible revenue depends on where gross receipts fall relative to the PTC thresholds.

How much capital has Constellation returned to shareholders, and how much remains?

Constellation repurchased about $500M of stock in Q2 2024, bringing year-to-date repurchases to roughly $1.0B and cumulative repurchases under the program to about $2.0B, covering about 16.1 million shares through August 6, 2024. About $1.0B of the $3.0B authorization remains. Dividends paid in the first six months were $222M.

Does this filing include all the company's financial disclosures for the quarter?

Not entirely. The 8-K furnishes the earnings press release and slides under Items 2.02 and 7.01 and states they are furnished rather than filed with the SEC. The full quarterly financial statements, detailed risk factors, and complete commitments disclosures are in the companion Form 10-Q, which was to be filed on August 6, 2024. Investors should review the 10-Q for complete GAAP detail and risk discussion.

CEG 8-K: Earnings & Results & Regulation FD

01—Abstract

Summary

Summary of the 8-K filed August 6, 2024. Cited figures are marked; the original filing is the authoritative source.

Constellation Energy (CEG) reported second-quarter 2024 results on August 6, 2024, with GAAP net income attributable to common shareholders of $814 million^a, or $2.58 per diluted share, versus $833 million ($2.56) a year earlier.

Adjusted (non-GAAP) operating earnings were $531 million^b, or $1.68 per share, up from $1.64 in Q2 2023. The GAAP figure was lifted by a $405 million after-tax unrealized gain on fair value adjustments, which the company excludes from its adjusted measure, so investors should focus on the $1.68 operating figure as the more representative run-rate. The headline for investors is the raise in full-year 2024 adjusted operating earnings guidance to $7.60-$8.40 per share, up from $7.23-$8.03.

Management attributed the increase to strong commercial portfolio performance in a volatile market, higher nuclear output (45,314 GWh versus 41,895 GWh), and lower refueling outage days, partly offset by higher O&M tied to stock-based compensation and commercial overperformance compensation. The company also highlighted the contribution from its newly acquired ownership interest in the South Texas Project and the nuclear production tax credit (PTC) benefit. Capital allocation remained shareholder-focused: about $500 million^c of stock was repurchased in Q2, bringing year-to-date repurchases to roughly $1.0 billion and cumulative repurchases under the program to about $2.0 billion, with approximately $1.0 billion of authorization remaining.

The presentation also flagged the 2025/2026 PJM capacity auction results, with the cleared price of $270^d/MW-day versus roughly $100 previously assumed, which management estimates could add $0.25 per share to 2025 and $1.25 per share to 2026 adjusted operating earnings. Investors should note that the filing is furnished rather than filed, and that the forward-looking estimates depend on market prices and the PTC phase-out structure.

02—Key points

Key Highlights

GAAP EPS of $2.58 (net income of $814M) versus $2.56 a year ago; adjusted operating EPS of $1.68 (adjusted earnings of $531M), up $0.04 year over year.
Full-year 2024 adjusted operating earnings guidance raised to $7.60-$8.40 per share from $7.23-$8.03, a midpoint increase of roughly $0.40 per share.
Q2 GAAP results include a $405M after-tax unrealized gain on fair value adjustments, which is excluded from adjusted operating earnings and should not be read as recurring operating performance.
Nuclear fleet generation rose to 45,314 GWh from 41,895 GWh, with a 95.4% capacity factor for sites excluding Salem and STP, and refueling outage days fell to 49 from 94.
Share repurchases of about $500M in Q2 (about $1.0B year to date; about $2.0B cumulative), with roughly $1.0B of program authorization remaining.
2025/2026 PJM capacity auction cleared at $270/MW-day, which management estimates adds about $0.25 per share to 2025 and $1.25 per share to 2026 adjusted operating earnings.
Operating revenues were $5,475M in Q2 2024 versus $5,446M a year earlier, while six-month operating income was $1,913M, and total liabilities rose modestly to $39.6B.

03—Questions

Frequently Asked Questions

Why is GAAP EPS of $2.58 much higher than adjusted operating EPS of $1.68?
The gap is primarily an unrealized gain of about $405M after tax (about $1.28 per share) from fair value adjustments on derivatives and nuclear decommissioning trust assets. Constellation excludes these mark-to-market and fair value movements from adjusted operating earnings because they are volatile and not indicative of ongoing operations, so the $1.68 figure is the company's preferred measure of underlying performance.
What drove the increase in full-year 2024 guidance?
Management cited commercial business performance ahead of plan in a volatile market, including strong wholesale and retail results, load auction wins, and margin expansion, along with successful portfolio optimization. Higher nuclear output, lower refueling outage costs, and the South Texas Project ownership contribution also supported results. These gains were partly offset by higher O&M from stock price-linked compensation and commercial overperformance pay.
How significant is the PJM capacity auction result for future earnings?
Management estimates the 2025/2026 PJM auction result, which cleared at $270/MW-day versus roughly $100/MW-day previously assumed, could add about $0.25 per share in 2025 and $1.25 per share in 2026 to adjusted operating earnings. These are estimates based on forward market prices as of July 31, 2024, and actual results may vary. The Illinois CMC contract is a comprehensive payment, so capacity price changes do not affect those units' economics, and the capacity impact on PTC-eligible revenue depends on where gross receipts fall relative to the PTC thresholds.
How much capital has Constellation returned to shareholders, and how much remains?
Constellation repurchased about $500M of stock in Q2 2024, bringing year-to-date repurchases to roughly $1.0B and cumulative repurchases under the program to about $2.0B, covering about 16.1 million shares through August 6, 2024. About $1.0B of the $3.0B authorization remains. Dividends paid in the first six months were $222M.
Does this filing include all the company's financial disclosures for the quarter?
Not entirely. The 8-K furnishes the earnings press release and slides under Items 2.02 and 7.01 and states they are furnished rather than filed with the SEC. The full quarterly financial statements, detailed risk factors, and complete commitments disclosures are in the companion Form 10-Q, which was to be filed on August 6, 2024. Investors should review the 10-Q for complete GAAP detail and risk discussion.

04—Continue

← View all 8-K filings